Xenios

2018-08-21T13:28:05+00:00

Thomas R. Villinger

ZFHN Partner:

2008 and 2013

Initial investment:

XENIOS AG is a medical technology company that is active in international markets, and focuses on therapies for the treatment of cardiac and pulmonary arrest.

Georg Matheis

Chief Executive and Founder

Thomas R. Villinger

ZFHN Partner:

2008 and 2013

Initial investment:

XENIOS AG is a medical technology company that is active in international markets, and focuses on therapies for the treatment of cardiac and pulmonary arrest.

Georg Matheis

Chief Executive and Founder

XENIOS is a leader in technologies and therapies for the minimally invasive support of pulmonary and cardiac functions.

The novalung iLA, i-cor and medos products offer the full range of pulmonary and cardiac support on the basis of the unique XENIOS platform. The novalung iLA therapy can replace or complement harmful and immobilizing respiration treatments. The i-cor therapy supports cardiac function with a pulse that is synchronous with the human heartbeat. These minimally invasive therapies make it possible to provide cardiac and pulmonary support to patients who are awake, able to function on their own, and mobile. In addition, these therapies make it possible to avoid both damage to and infections in the lungs caused by artificial respiration, and the atrophy of the respiratory musculature.

Thanks to the professional support from ZFHN over the course of many years, we at Xenios are now in a position to take the next important steps.

Georg Matheis

Chief Executive and Founder

Thanks to the professional support from ZFHN over the course of many years, we at Xenios are now in a position to take the next important steps.

Georg Matheis

Chief Executive and Founder

2008
Investment by ZFHN in Novalung (manufacturer of artificial lungs)
2013
Investment by ZFHN in Medos Medizintechnik AG (manufacturer of systems for pumping blood)
2013
Fusion of the two companies and founding of Xenios AG
2016
ZFHN sells its shares to Fresenius Medical Care AG & Co.KGaA